Treatment of Helicobacter pylori infection: a review of the world literature.
about
Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistanceNew concepts of resistance in the treatment of Helicobacter pylori infectionsHelicobacter pyloriVaccine against Helicobacter pylori: Inevitable approachClarithromycin vs. furazolidone in quadruple therapy regimens for the treatment of Helicobacter pylori in a population with a high metronidazole resistance rate.Five-day proton pump inhibitor-based quadruple therapy regimen is more effective than 7-day triple therapy regimen for Helicobacter pylori infection.Practical advice on eradicating Helicobacter pylori infection.Pharmacokinetic interactions between ilaprazole and clarithromycin following ilaprazole, clarithromycin and amoxicillin triple therapy.Helicobacter pylori antibody responses in association with eradication outcome and recurrence: a population-based intervention trial with 7.3-year follow-up in China.A systematic review of Helicobacter pylori eradication therapy--the impact of antimicrobial resistance on eradication rates.Varying efficacy of Helicobacter pylori eradication regimens: cost effectiveness study using a decision analysis model.Regular review: treatment of Helicobacter pylori infection.Review article: nitroimidazole resistance in Helicobacter pylori.Helicobacter pylori is not eradicated after triple therapy: a nested PCR based studyA meta-analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxycillin for treating Helicobacter pylori infection.High-dose extended-release lansoprazole (dexlansoprazole) and amoxicillin dual therapy for Helicobacter pylori infectionsHelicobacter pylori uptake and efflux: basis for intrinsic susceptibility to antibiotics in vitroPooled analysis of Helicobacter pylori eradication regimes in Asia.Review article: alternative antibacterial agents for Helicobacter pylori eradication.A novel therapeutic approach for Helicobacter pylori infection: the bismuth-based triple therapy monocapsule.Short-duration furazolidone therapy in combination with amoxicillin, bismuth subcitrate, and omeprazole for eradication of Helicobacter pylori.Helicobacter pylori infection in hemodialysis patients: susceptibility to amoxicillin and clarithromycinResponse of blood endothelin-1 and nitric oxide activity in duodenal ulcer patients undergoing Helicobacter pylori eradicationDual versus triple therapy of Helicobacter pylori infection: results of a multicentre trial.Influence of metronidazole resistance on efficacy of quadruple therapy for Helicobacter pylori eradication.Increasing the duration of dual amoxicillin plus omeprazole Helicobacter pylori eradication to 6 weeks: a pilot studyThe Helicobacter pylori eradication in the group receiving standard -dose and group continue taking amoxicillin for 4 weeks; a clinical trial study.Inclusion of Lactobacillus Reuteri in the Treatment of Helicobacter pylori in Sardinian Patients: A Case Report SeriesRapid increase in the prevalence of metronidazole-resistant Helicobacter pylori in the Netherlands.How to Effectively Use Bismuth Quadruple Therapy: The Good, the Bad, and the Ugly.Role of bismuth in improving Helicobacter pylori eradication with triple therapy.Double-blind comparison of absorbable colloidal bismuth subcitrate and nonabsorbable bismuth subnitrate in the eradication of Helicobacter pylori and the relief of nonulcer dyspepsia.Review: eradication of Helicobacter pylori. Problems and recommendations.In vitro anti-Helicobacter pylori activities of new rifamycin derivatives, KRM-1648 and KRM-1657.Multiplex sequence analysis demonstrates the competitive growth advantage of the A-to-G mutants of clarithromycin-resistant Helicobacter pylori.Subpopulations of Helicobacter pylori are responsible for discrepancies in the outcome of nitroimidazole susceptibility testing.Rapid detection, by PCR and reverse hybridization, of mutations in the Helicobacter pylori 23S rRNA gene, associated with macrolide resistance.Sensitivity of amoxicillin-resistant Helicobacter pylori to other penicillins.Accurate prediction of macrolide resistance in Helicobacter pylori by a PCR line probe assay for detection of mutations in the 23S rRNA gene: multicenter validation studyGenotypic characterization of clarithromycin-resistant and -susceptible Helicobacter pylori strains from the same patient demonstrates existence of two unrelated isolates.
P2860
Q24548472-7B78FC1E-658C-4272-9280-DDB11A35300FQ24622513-55221230-B568-4178-AE6B-176A34B2B098Q24683623-509BDFF0-D4A3-46AF-9DF2-E69491ADB7E8Q26752743-A1B4D153-E710-4A3F-87A8-3F98329F056AQ32026744-E0FA8E2D-E065-4512-B057-114834594B53Q32026771-6BF41272-714F-4254-AE43-AAE922491739Q33543499-C6ABE6FF-72F9-4439-AB2F-9B7ED6EDC5B1Q33571277-B9B8D701-67AB-42D1-8E4E-EE4E4D9F757AQ33649953-1F278E4A-53FE-438C-B390-AF790BA552F5Q33723548-1376843E-A4A0-46C2-8A33-8E4A0CFECA6AQ33797261-F2440D2C-D673-4146-B51C-5DAB88DEA3ECQ33807123-94569BEA-3481-4BF0-B976-2B0AECA84A22Q33815739-77CCF46B-38AE-4402-B51D-967E5F41EBB9Q33891371-D882C48E-248E-49A8-9AA6-2C21084CF738Q33904326-4348259A-0168-48C9-BB6F-882EED886AEBQ33953262-D8FA586B-EBDF-4BF4-9F5C-6BF31CB25CA6Q33978620-718620FF-4570-4242-9C04-2081D6CF5D9DQ34074306-C59B3035-DDD6-46C3-BD59-7FD751EFA9F4Q34374147-93B8C71D-2BBB-467F-9181-163A597D2A98Q34481671-2FE492B0-8019-4000-84E5-4AA83D58F35BQ34501295-295A8E7E-78DC-4611-B031-9F124B0DC7DEQ34604699-C94DBCDE-15A5-489E-8B27-ABBA3AD0C36FQ34605564-EB3B0392-C839-4F2F-A5B2-C838CF4CA3C2Q35263613-BD8FB6AE-9020-4011-901E-32ACA9F021C5Q35349548-10C417B3-81E6-4C47-BE0E-38B5FDD34ACEQ35539764-334E5940-FE74-44D9-A2F5-D7CEFD78DC3EQ35830094-0D754B45-BE11-43A4-82F1-7B254DFBB1C5Q36822577-CDD0CBAD-4DEB-448C-B79D-2E73945C1C05Q37064210-EB8DA8FF-C6F2-4A8B-BC34-10CE9F596170Q38575216-2246E0F6-5D2B-4E6C-AF4D-48A77CBF6D13Q38723877-94401753-C297-487A-A3A7-EDBF2C586B19Q39427014-0D06622D-736D-41F2-BA9B-235DDF7CF081Q39453816-01E6B510-C683-4224-B532-A00E552C4D91Q39470015-1471E923-5061-49DA-88D3-ED4B76DBFA20Q39470356-D8AC3CEE-01D1-4740-B061-AB618AA7C389Q39470987-3F49DE9A-567E-401F-8EDD-BCF42A7E5883Q39471335-4CCD1C9B-496A-4FCA-9CA1-F383802CD51BQ39471361-C8EC38A7-14AC-4826-BCC4-9ACF03635036Q39477186-B4D63970-F7C6-472B-8B27-ACEA30E5D98CQ39555559-1BCAE1F4-D691-45C0-8C55-9F9BB47C0DF5
P2860
Treatment of Helicobacter pylori infection: a review of the world literature.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Treatment of Helicobacter pylori infection: a review of the world literature.
@en
type
label
Treatment of Helicobacter pylori infection: a review of the world literature.
@en
prefLabel
Treatment of Helicobacter pylori infection: a review of the world literature.
@en
P2093
P2860
P1433
P1476
Treatment of Helicobacter pylori infection: a review of the world literature.
@en
P2093
van der Hulst RW
P2860
P356
10.1111/J.1523-5378.1996.TB00003.X
P577
1996-03-01T00:00:00Z